Related Experiment Videos
Anti-platelet aggregation activity of stilbene derivatives from Rheum undulatum
Archives of Pharmacal Research
|September 18, 1999
Summary
Korean rhubarb compounds rhapontigenin and desoxyrhapontigenin effectively inhibit blood platelet aggregation. These findings suggest a potential role for these stilbenes in improving blood circulation and preventing stagnation.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Traditional Medicine
Background:
- Cultivated Korean rhubarb (Rheum undulatum) is utilized in traditional medicine.
- Stilbenes are a class of natural compounds with diverse biological activities.
- Blood platelet aggregation plays a critical role in thrombosis and hemostasis.
Purpose of the Study:
- To evaluate the anti-platelet aggregation activity of three known stilbenes isolated from Korean rhubarb.
- To identify specific compounds responsible for the potential blood-stagnancy-alleviating effects of rhubarb.
Main Methods:
- Isolation and identification of three stilbenes: desoxyrhapontigenin, rhapontigenin, and piceatannol from Rheum undulatum rhizomes.
- In vitro screening of these stilbenes for their inhibitory effects on platelet aggregation induced by arachidonic acid and collagen.
Main Results:
- Rhapontigenin and desoxyrhapontigenin demonstrated significant inhibition of platelet aggregation.
- Piceatannol did not exhibit any inhibitory activity on platelet aggregation.
- The inhibitory effects were observed against both arachidonic acid- and collagen-induced aggregation.
Conclusions:
- Rhapontigenin and desoxyrhapontigenin possess potent anti-platelet aggregation properties.
- These identified stilbenes may contribute to the traditional use of rhubarb for improving blood circulation.
- Further research is warranted to explore the therapeutic potential of these compounds in cardiovascular health.